Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$79M
-
Put/Call ratio
-
1.56
-
Number of buys
-
76
-
Number of sells
-
-67
-
Price
-
$50.67
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2017
163 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q2 2017.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 65M outstanding shares and own 54.71% of the company stock.
Largest 10 shareholders include FMR LLC (5.3M shares), WELLINGTON MANAGEMENT GROUP LLP (3.11M shares), BlackRock Inc. (2.86M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.47M shares), LORD, ABBETT & CO. LLC (1.73M shares), BVF INC/IL (1.59M shares), OppenheimerFunds, Inc. (1.53M shares), VANGUARD GROUP INC (1.42M shares), STATE STREET CORP (1.4M shares), and Partner Fund Management, L.P. (1.29M shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.